Literature DB >> 11813853

Portal and mesenteric vein and inferior vena cava thrombosis associated with antiphospholipid syndrome.

M Higa1, M Kojima, S Ohnuma, S Hamanaka, W Yamamuro, H Sugiura, M Sato.   

Abstract

We report a 48-year-old man with thrombosis of the portal and superior mesenteric vein and inferior vena cava associated with primary antiphospholipid syndrome (APS). Primary APS was diagnosed by a positive reaction with anticardiolipin antibody (aCL) and the absence of any evidence suggesting the presence of other disease states known to be associated with aCL. A coeliac angiography showed obstruction of the portal and superior mesenteric vein with prominent collaterals and cavernous transformation. Femoral vein angiography showed total obstruction of the external iliac vein and inferior vena cava, and dilation of the pelvic veins, with contrast medium in the lumbar vein. This case is noteworthy as a report of primary APS accompanied by extensive abdominal and pelvic venous thrombosis.

Entities:  

Mesh:

Year:  2001        PMID: 11813853     DOI: 10.2169/internalmedicine.40.1245

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Endoscopically removed hepatolithiasis associated with cavernous transformation of the portal vein and antiphospholipid antibody syndrome.

Authors:  Keisuke Okudaira; Atsushi Kawaguchi; Takuya Inoue; Kazutoshi Hashiguchi; Yoshikazu Tsuzuki; Shigeaki Nagao; Kazuro Itoh; Soichiro Miura
Journal:  Dig Dis Sci       Date:  2006-10-24       Impact factor: 3.199

2.  Portal vein thrombosis in a patient with hepatitis C virus-related cirrhosis complicated with antiphospholipid syndrome.

Authors:  Yohei Kida; Etsuko Maeshima; Yoichi Yamada
Journal:  Rheumatol Int       Date:  2009-01-28       Impact factor: 2.631

3.  Antiphospholipid syndrome presenting as acute mesenteric venous thrombosis involving a variant inferior mesenteric vein and successful treatment with rivaroxaban.

Authors:  Kevin Singh; Gulam Khan
Journal:  BMJ Case Rep       Date:  2018-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.